Cobalamins Function as Allosteric Activators of an Angelman Syndrome‐Associated UBE3A/E6AP Variant
Abstract: Genetic aberrations of the maternal UBE3A allele, which encodes the E3 ubiquitin ligase E6AP, are the cause of Angelman syndrome (AS), an imprinting disorder. In most cases, the maternal UBE3A allele is not expressed. Yet, approximately 10 percent of AS individuals harbor distinct point mutations in the maternal allele resulting in the expression of full‐length E6AP variants that frequently display compromised ligase activity. In a high‐throughput screen, we identified cyanocobalamin, a vitamin B12‐derivative, and several alloxazine derivatives as activators of the AS‐linked E6AP‐F583S variant. Furthermore, we show by cross‐linking coupled to mass spectrometry that cobalamins affect the structural dynamics of E6AP‐F583S and apply limited proteolysis coupled to mass spectrometry to obtain information about the regions of E6AP that are involved in, or are affected by binding cobalamins and alloxazine derivatives. Our data suggest that dietary supplementation with vitamin B12 can be beneficial for AS individuals.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Cobalamins Function as Allosteric Activators of an Angelman Syndrome‐Associated UBE3A/E6AP Variant ; day:02 ; month:05 ; year:2024 ; extent:7
ChemBioChem ; (02.05.2024) (gesamt 7)
- Urheber
-
Müller, Franziska
Jansen, Jasmin
Offensperger, Fabian
Eichbichler, Daniela
Stengel, Florian
Scheffner, Martin
- DOI
-
10.1002/cbic.202400184
- URN
-
urn:nbn:de:101:1-2405031405186.548104325605
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Müller, Franziska
- Jansen, Jasmin
- Offensperger, Fabian
- Eichbichler, Daniela
- Stengel, Florian
- Scheffner, Martin
Ähnliche Objekte (12)
Cobalamins function as allosteric activators of an Angelman syndrome‐associated UBE3A/E6AP variant
Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants
Outcome measures in Angelman syndrome
Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase
A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry
Epilepsy in patients with Angelman syndrome
Sleep disturbance in Angelman syndrome patients
On-target and off-target effects of novel orthosteric and allosteric activators of GPR84
Clinical, Molecular, and Neurophysiological Features in Angelman Syndrome
Cortical and subcortical morphological alteration in Angelman syndrome
Design, synthesis and evaluation of novel 3,5-disubstituted benzamide derivatives as allosteric glucokinase activators
An Overview of the Adaptive Behaviour Profile in Young Children with Angelman Syndrome: Insights from the Global Angelman Syndrome Registry
Cobalamins function as allosteric activators of an Angelman syndrome‐associated UBE3A/E6AP variant
Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants
Outcome measures in Angelman syndrome
Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase
A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry
Epilepsy in patients with Angelman syndrome
Sleep disturbance in Angelman syndrome patients
On-target and off-target effects of novel orthosteric and allosteric activators of GPR84
Clinical, Molecular, and Neurophysiological Features in Angelman Syndrome
Cortical and subcortical morphological alteration in Angelman syndrome
Design, synthesis and evaluation of novel 3,5-disubstituted benzamide derivatives as allosteric glucokinase activators
An Overview of the Adaptive Behaviour Profile in Young Children with Angelman Syndrome: Insights from the Global Angelman Syndrome Registry
Cobalamins function as allosteric activators of an Angelman syndrome‐associated UBE3A/E6AP variant
Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants
Outcome measures in Angelman syndrome
Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase
A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry
Epilepsy in patients with Angelman syndrome
Sleep disturbance in Angelman syndrome patients
On-target and off-target effects of novel orthosteric and allosteric activators of GPR84
Clinical, Molecular, and Neurophysiological Features in Angelman Syndrome
Cortical and subcortical morphological alteration in Angelman syndrome
Design, synthesis and evaluation of novel 3,5-disubstituted benzamide derivatives as allosteric glucokinase activators